Hims & Hers Health (HIMS) Net Equity Issued and Repurchased (2020)

Hims & Hers Health (HIMS) posted Net Equity Issued and Repurchased of -$27000.0 for Q4 2020, down 100.19% sequentially from $14.4 million in Q3 2020.

Hims & Hers Health (HIMS) Net Equity Issued and Repurchased (2020) Analysis & Trends

Hims & Hers Health has reported Net Equity Issued and Repurchased for 1 years, with the latest figure at -$27000.0 in Q4 2020.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$27000.0 in Q4 2020, while the trailing twelve-month figure through Sep 2021 was -$27000.0 (changed N/A YoY) and the FY2020 annual result came in at $51.9 million, down 49.4% from the prior year.
Net Equity Issued and Repurchased eased to -$27000.0 in Q4 2020 per HIMS's latest filing, from $14.4 million in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $31.6 million in Q1 2020 and troughed at -$27000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	-
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	700,000.00
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	84.80 Mn
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	Hims & Hers Health	7.81 Bn	6.97 Bn	480.80 Mn	-

Download Data